A new study tracking thousands of B cells across more than 100 germinal centers in mice reveals how the system consistently ...
The Israeli study examined tumor samples and nearby lymph nodes from 11 patients with high-grade serous ovarian cancer.
19don MSN
Immune memory cells in ovarian cancer produce tumor-targeting antibodies, opening a vaccine path
While we tend to quickly forget having been ill or having received a vaccine, the immune system remembers remarkably well. It has memory B cells—"trained" immune cells that circulate throughout the ...
French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in mice and ...
The results from both studies were presented in two poster presentations (abstracts PS2082 and PF1007) at the European Hematology Association (EHA) 2026 Congress held in Stockholm, Sweden, June 11-14.
The Cyto-Mine ® platform by Fluidic Sciences and Sphere Bio utilizes innovative picodroplet-based technology to capture and screen antibodies directly from entire B cell repertoires, maintaining cell ...
Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting cells to ...
The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a study led by researchers from the Penn State College of Medicine has ...
Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results